<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>Biobank | LiquidMammo™</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta
    name="description"
    content="The MultiOmics Biobank supports LiquidMammo discovery and validation with longitudinal breast‑cancer samples dating back to 2008, enabling rapid retrospective performance testing of microRNA-based panels."
  />
  <link rel="stylesheet" href="assets/css/styles.css" />
  <link rel="icon" href="favicon.png" type="image/png" />
</head>

<body>

<header class="container">
  <nav><a href="index.html">← Home</a></nav>
</header>

<main class="container">

  <h1>MultiOmics Biobank</h1>

  <!-- Overview -->
  <section class="section-tight">
    <p>
      The MultiOmics Biobank is a longitudinal breast‑cancer resource that enables rapid, retrospective
      discovery and validation of <span class="scientific-term">microRNA</span> diagnostic panels for
      screening support. Its depth and historical span make it possible to test candidate signatures against
      known outcomes—accelerating iteration prior to prospective studies.
    </p>
  </section>

  <!-- At-a-glance / Proof points -->
  <section class="panel-light section-tight">
    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">
      <div class="card">
        <h3>Scale &amp; history</h3>
        <p>
          ~20,000 breast‑cancer samples with longitudinal clinical context, including cohorts reaching back to
          <strong>2008</strong>—enabling immediate retrospective performance assessment of candidate panels.
        </p>
      </div>
      <div class="card">
        <h3>Consent &amp; provenance</h3>
        <p>
          The DNA consent pathway was originally developed at <strong>Baylor</strong>; samples/data are held
          and managed by <strong>MultiOmics</strong> with consent‑based access controls.
        </p>
      </div>
    </div>
  </section>

  <!-- What we bank -->
  <section class="section-tight">
    <h2>What we bank</h2>
    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">
      <div class="card-mini">
        <h4>Specimens</h4>
        <p class="small">
          Blood‑based materials suitable for <span class="scientific-term">microRNA</span> profiling; where
          available, paired tissue and additional biospecimens are linked to support biology‑aware modeling.
          Pre‑analytical SOPs and QC criteria are shared on request.
        </p>
      </div>
      <div class="card-mini">
        <h4>Linked clinical data</h4>
        <p class="small">
          Longitudinal context (e.g., diagnosis, subtype assignment, imaging/biopsy confirmation, and select
          time‑to‑event variables when available) supports rigorous label definition for training and validation.
          All datasets are de‑identified prior to release.
        </p>
      </div>
    </div>
  </section>

  <!-- Use cases -->
  <section class="section-tight">
    <h2>How investigators use the biobank</h2>
    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">
      <div class="card-mini">
        <h4>Discovery</h4>
        <p class="small">
          Identify and refine candidate <span class="scientific-term">microRNA</span> signatures associated
          with cancer presence and molecular subtype; optimize normalization, feature selection, and model
          calibration.
        </p>
      </div>
      <div class="card-mini">
        <h4>Retrospective validation</h4>
        <p class="small">
          Quantify sensitivity, specificity, AUC, and calibration using historical samples with known outcomes
          to de‑risk prospective studies and subgroup analyses (e.g., density‑stratified).
        </p>
      </div>
    </div>
  </section>

  <!-- Governance -->
  <section id="governance" class="panel-light section-tight">
    <h2>Governance &amp; participant protections</h2>
    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">
      <div class="card-mini">
        <h4>Consent &amp; privacy</h4>
        <p class="small">
          All access is consent‑driven and governed by data‑minimization and privacy safeguards. Only
          de‑identified data leave MultiOmics environments. Secondary use must align with the original
          consent scope.
        </p>
      </div>
      <div class="card-mini">
        <h4>Scientific &amp; ethics review</h4>
        <p class="small">
          Requests undergo documented review for scientific merit, feasibility, analytics plan, and ethical
          compliance. Where applicable, requesters provide IRB determination and a data‑security plan.
        </p>
      </div>
    </div>
  </section>

  <!-- Access -->
  <section id="access" class="section">
    <h2>Accessing the biobank</h2>
    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">
      <div class="card">
        <h3>Who can apply</h3>
        <p>
          Academic, clinical, or industry researchers with a focus on diagnostic discovery, validation,
          or clinical utility. Prioritization is given to projects that address early detection,
          dense‑breast limitations, or subtype‑aware decision pathways.
        </p>
      </div>
      <div class="card">
        <h3>How to request</h3>
        <ol class="list-tight">
          <li>Submit a 2–3 page concept with aims, endpoints, cohorts, and dataset needs.</li>
          <li>Provide IRB status (if applicable) and a brief data‑security plan.</li>
          <li>Agree to data‑use terms and attribution language.</li>
        </ol>
        <div style="margin-top:12px;display:flex;gap:10px;flex-wrap:wrap;">
          <a class="btn" href="contact.html#biobank">Start a Request</a>
          <a class="btn secondary" href="privacy.html#data-use">Data Use &amp; Privacy</a>
        </div>
      </div>
    </div>
  </section>

  <!-- FAQ -->
  <section class="section-tight">
    <h2>Frequently asked</h2>
    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">
      <div class="card-mini">
        <h4>Do you share raw or processed data?</h4>
        <p class="small">
          Both are supported depending on consent and review scope. For discovery, raw plus minimal metadata
          are common; for validation, processed matrices and analysis recipes may be approved to speed execution.
        </p>
      </div>
      <div class="card-mini">
        <h4>Turnaround time</h4>
        <p class="small">
          Timelines depend on request complexity and review requirements. Well‑scoped validation requests
          are typically faster than complex, multi‑arm discovery studies.
        </p>
      </div>
    </div>
  </section>

</main>

<footer>
  <div class="container footer-grid">
    <div>
      <strong>LiquidMammo™</strong><br/>
      A test developed by MultiOmics Inc.
      <p class="footer-note">
        MultiOmics Inc. is headquartered in Washington, DC, and operates out of LabCentral,
        Cambridge, MA (MIT innovation ecosystem).
      </p>
    </div>
    <div class="footer-logo" style="justify-content:flex-end;text-align:right">
      <img src="assets/logos/multiomics-logo.png" alt="MultiOmics Inc. logo (subtle)" />
      <div class="footer-note" style="line-height:1.2">Developed by<br/>MultiOmics Inc.</div>
    </div>
  </div>
  <div class="container footer-note">
    © <script>document.write(new Date().getFullYear())</script> MultiOmics Inc. •
    <a href="privacy.html">Privacy &amp; Compliance</a> •
    <a href="contact.html">Order / Kits</a>
  </div>
</footer>

</body>
</html>



